- Home
- / POINT Biopharma Global
POINT Biopharma Global
Stock Price
$12.5
2023-12-26
Market Capitalization
$1.3 B
2023-12-26
POINT Biopharma Global Summary
Company Summary
- Overview
- POINT Biopharma Global is a radiopharmaceutical company that specializes in cancer treatment solutions. It develops radioligand therapies to diagnose and treat non-Hodgkins lymphoma, neuroendocrine tumors (NETs), and prostate cancer.
- Type
- Public
- Status
- Active
- Founded
- 2019
- Cybersecurity rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026